Mood Disorders
|
0.400 |
Biomarker
|
group |
BEFREE |
Thus, epistasis between BDNF and HTR1A may contribute to the multifactorial risk for affective disorders and our results strongly advocate further research on this genetic signature in affective disorders.
|
30664620 |
2019 |
Mood Disorders
|
0.400 |
GeneticVariation
|
group |
BEFREE |
The primary goal of this study was to determine the possible association between polymorphisms of genes encoding the serotonin receptors 5HT1A (rs6295), 5HT1B (rs6296), and 5HT2C (rs6318) and the presence of mood disorders in patients with TLE-HS.
|
29709878 |
2018 |
Mood Disorders
|
0.400 |
Biomarker
|
group |
BEFREE |
The serotonin-1A (5-HT1A) receptor is strongly implicated in major depression and other affective disorders due to its negative regulation of serotonin neurone firing rates.
|
28970569 |
2017 |
Mood Disorders
|
0.400 |
Biomarker
|
group |
BEFREE |
The clinical implications of targeting alexithymia and HTR1A receptors as a possible treatment option for mood disorders should be investigated in further studies.
|
26609890 |
2015 |
Mood Disorders
|
0.400 |
Biomarker
|
group |
BEFREE |
This study suggests that serotonin signaling through postsynaptic 5-HT1A receptors in the hippocampus is critical for the antidepressant-like effects of a cholinergic drug and begins to elucidate the molecular mechanisms underlying interactions between the serotonergic and cholinergic systems related to mood disorders.
|
25288485 |
2015 |
Mood Disorders
|
0.400 |
GeneticVariation
|
group |
BEFREE |
History of mood disorders and HTR1A G allele variation, the C-1019G polymorphism of the transcriptional control region of the 5-HT1A receptor, independently predicted the incidence of IFN-induced depression in HCV patients, whether separately or jointly considered and although not reciprocally associated.
|
26001668 |
2015 |
Mood Disorders
|
0.400 |
Biomarker
|
group |
PSYGENET |
In MDD, however, the effect of the val66met polymorphism is not detectable, possibly due to a ceiling effect of over-expression of 5-HT(1A) receptors in mood disorders.
|
24607934 |
2014 |
Mood Disorders
|
0.400 |
GeneticVariation
|
group |
BEFREE |
In MDD, however, the effect of the val66met polymorphism is not detectable, possibly due to a ceiling effect of over-expression of 5-HT(1A) receptors in mood disorders.
|
24607934 |
2014 |
Mood Disorders
|
0.400 |
Biomarker
|
group |
PSYGENET |
RGS6 is enriched in hippocampal and cortical neurons, 5-HT(1A)R-expressing cells implicated in mood disorders.
|
24421401 |
2014 |
Mood Disorders
|
0.400 |
Biomarker
|
group |
PSYGENET |
Results from this expanded meta-analysis, which included our own new study, suggest that rs6295 (C-1019G) and rs878567 in HTR1A are related to the pathophysiology of MDs, with overlap between MDD and BP.
|
22752684 |
2013 |
Mood Disorders
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Results from this expanded meta-analysis, which included our own new study, suggest that rs6295 (C-1019G) and rs878567 in HTR1A are related to the pathophysiology of MDs, with overlap between MDD and BP.
|
22752684 |
2013 |
Mood Disorders
|
0.400 |
Biomarker
|
group |
PSYGENET |
Altered regulation of the serotonin-1A (5-HT1A) receptor gene is implicated in major depression and mood disorders.
|
22232550 |
2012 |
Mood Disorders
|
0.400 |
Biomarker
|
group |
PSYGENET |
Due to its modulatory effect on serotonin (5-HT) release, the 5-HT(1A)-receptor is thought to play a decisive role in the therapy of this mood disorder.
|
21419787 |
2011 |
Mood Disorders
|
0.400 |
Biomarker
|
group |
BEFREE |
Serotonin (5-hydroxytryptamine, 5-HT) neurotransmission is negatively regulated by 5-HT1A autoreceptors on raphe neurons, and is implicated in mood disorders.
|
21182526 |
2011 |
Mood Disorders
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Three genes contributed exclusively to mood disorders, one through a main effect (HTR5A (rs1657268)) and two through gene-environment interactions with CPA (HTR1A (rs878567) and SLC6A4 (rs3794808)).
|
19381154 |
2010 |
Mood Disorders
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Altered expression of serotonin-1A (5-HT1A) receptors, both presynaptic in the raphe nuclei and post-synaptic in limbic and cortical target areas, has been implicated in mood disorders such as major depression and anxiety.
|
19423080 |
2009 |
Mood Disorders
|
0.400 |
GeneticVariation
|
group |
BEFREE |
5-HT1A gene variants have been reported to play some role in mood disorders, anxiety disorders and psychotic disorders.
|
18047755 |
2008 |
Mood Disorders
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Gene-gene interaction studies suggest that the 5-HT1A receptor G(-1019) allele is a risk allele which could be used as a marker for depression and related mood disorders.
|
18639564 |
2008 |
Mood Disorders
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Alterations in 5-HT1A receptor levels are implicated in mood disorders, and a functional C(-1019)G 5-HT1A promoter polymorphism has been associated with depression, suicide, and panic disorder.
|
16467535 |
2006 |
Mood Disorders
|
0.400 |
Biomarker
|
group |
BEFREE |
These results indicate an important (mainly inhibitory) role of galanin as a regulator of brain serotonin and 5-HT1A receptor-mediated transmission, which may be of potential importance for understanding mood disorders and for the development of antidepressant drugs.
|
16863269 |
2006 |
Mood Disorders
|
0.400 |
GeneticVariation
|
group |
BEFREE |
5-HT 1A polymorphism and self-transcendence in mood disorders.
|
15952185 |
2005 |
Mood Disorders
|
0.400 |
GeneticVariation
|
group |
LHGDN |
We tested involvement of 5-HT(1A) gene in this trait, in a sample of 40 remitted mood disorder patients.
|
15952185 |
2005 |
Mood Disorders
|
0.400 |
GeneticVariation
|
group |
BEFREE |
The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings.
|
15458611 |
2004 |
Mood Disorders
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Alterations in 5-HT(1A,) 5-HT(1B), and 5-HT(2A) mRNA levels in the brains of subjects with both mood disorders and schizophrenia add further support for hypothesis of dysregulation of the serotonergic system in these psychiatric disorders.
|
14744462 |
2004 |
Mood Disorders
|
0.400 |
Biomarker
|
group |
BEFREE |
Alterations in 5-HT(1A,) 5-HT(1B), and 5-HT(2A) mRNA levels in the brains of subjects with both mood disorders and schizophrenia add further support for hypothesis of dysregulation of the serotonergic system in these psychiatric disorders.
|
14744462 |
2004 |